Page 102 - 南京医科大学自然版
P. 102

第45卷第8期
               ·1158 ·                           南 京    医 科 大 学 学         报                        2025年8月


              and ZHENG Yuanru were responsible for data collection and  transplant and access to living donation[J]. JAMA Surg,
              analysis;XU Hexiang and ZHENG Jishun were responsible for  2021,156(11):1010-1017
              organizing and analyzing data,as well as creating charts and  [13]WIERING L,AIGNER A,VAN ROSMALEN M,et al. Sys⁃
              graphs;ZHENG Jishun was responsible for research and design  tematic sex⁃based inequity in the MELD score⁃based allo⁃
              guidance,manuscript revision,and final draft.          cation system for liver transplantation in germany[J].
                                                                     Transpl Int,2025,38:13844
             [参考文献]
                                                                [14]TEJEDOR M,NERIA F,DE LA ROSA G,et al. Women
             [1] VILLANUEVA C,TRIPATHI D,BOSCH J. Preventing         are also disadvantaged in accessing transplant outside the
                   the progression of cirrhosis to decompensation and  United States:analysis of the Spanish liver transplanta⁃
                   death[J]. Nat Rev Gastroenterol Hepatol,2025,22(4):  tion registry[J]. Transpl Int,2024,37:12732
                   265-280                                      [15]ALLEN A M,HEIMBACH J K,LARSON J J,et al. Re⁃
             [2] GINÈS P,KRAG A,ABRALDES J G,et al. Liver cir⁃       duced access to liver transplantation in women:role of
                   rhosis[J]. Lancet,2021,398(10308):1359-1376       height,MELD exception scores,and renal function under⁃
             [3] 窦科峰,张 玄,杨志鹏. 中国肝移植的发展与挑战[J].                        estimation[J]. Transplantation,2018,102(10):1710-
                   中华外科杂志,2024,62(1):1-5                             1716
                   DOU K F,ZHANG X,YANG Z P. Developments and   [16]CLÀRIA J,AGUILAR F,LOZANO JJ,et al. Albumin re⁃
                   challenges of liver transplantation in China[J]. Chinese  programs the B cell transcriptional landscape and im⁃
                   Journal of Surgery,2024,62(1):1-5                 proves neutrophil antimicrobial function in patients with
             [4] Chinese Society of Gastroenterology,Chinese Medical As⁃  decompensated cirrhosis[J]. JHEP Rep,2024,6(11):
                   sociation. Chinese consensus on the management of liver  101184
                   cirrhosis[J]. J Dig Dis,2024,25(6):332-352   [17]LI M,GE Y,WANG J,et al. Impact of albumin infusion
             [5] MALINCHOC M,KAMATH P S,GORDON F D,et al. A          on prognosis in ICU patients with cirrhosis and AKI:in⁃
                   model to predict poor survival in patients undergoing tran⁃  sights from the MIMIC⁃Ⅳ database[J]. Front Pharmacol,
                   sjugular intrahepatic portosystemic shunts[J]. Hepatolo⁃  2024,15:1467752
                   gy,2000,31(4):864-871                        [18]CARACENI P,TUFONI M,ZACCHERINI G,et al. On⁃
             [6] KAMATH P S,WIESNER R H,MALINCHOC M,et al. A         treatment serum albumin level can guide long⁃term treat⁃
                   model to predict survival in patients with end⁃stage liver  ment in patients with cirrhosis and uncomplicated asci⁃
                   disease[J]. Hepatology,2001,33(2):464-470         tes[J]. J Hepatol,2021,74(2):340-349
             [7] BIGGINS S W,KIM W R,TERRAULT N A,et al. Evi⁃   [19]YOO J J,CHANG J I,MOON J E,et al. Validation of
                   dence⁃based incorporation of serum sodium concentration  MELD 3.0 scoring system in East Asian patients with cir⁃
                   into MELD[J]. Gastroenterology,2006,130(6):1652-1660  rhosis awaiting liver transplantation[J]. Liver Transplant,
             [8] KIM W R,MANNALITHARA A,HEIMBACH J K,et al.          2023,29(10):1029-1040
                   MELD 3.0:the model for end⁃stage liver disease updated  [20]LIM J,KIM J H,KIM S E,et al. Validation of MELD 3.0
                   for the modern era[J]. Gastroenterology,2021,161(6):  in patients with alcoholic liver cirrhosis using prospective
                   1887-1895.e4                                      KACLiF cohort[J]. J Gastroenterol Hepatol,2024,39
             [9] MAZUMDER N R,FONTANA R J. MELD 3.0 in ad⁃          (9):1932-1938
                   vanced chronic liver disease[J]. Annu Rev Med,2024,  [21]LIN H Y,LOI P L,NG J,et al. MELD3.0 is superior to
                   75:233-245                                        MELDNa and MELD for prediction of mortality in pa⁃
             [10]中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝                         tients with cirrhosis:an external validation in a multi⁃eth⁃
                   脏病杂志,2019,27(11):846-865                          nic population[J]. JGH Open,2024,8(6):e13098
                   Chinese Society of Hepatology,Chinese Medical Associa⁃  [22]SONG J L,WANG X Z,YAN Y L,et al. MELD 3.0 Score
                   tion. Chinese guidelines on the management of liver cir⁃  for predicting survival in patients with cirrhosis after ttran⁃
                   rhosis[J]. Chinese Journal of Hepatology,2019,27(11):  sjugular intrahepatic portosystemic shunt creation[J].
                   846-865                                           Dig Dis Sci,2023,68(7):3185-3192
             [11]LUCA A,ANGERMAYR B,BERTOLINI G,et al. An in⁃   [23]郭北辰,李雨韩,陈        蕊,等. MELD 3.0、MELD和MELD
                   tegrated MELD model including serum sodium and age  ⁃Na 评分对慢加急性肝衰竭患者短期预后的评估价
                   improves the prediction of early mortality in patients with  值[J]. 临床肝胆病杂志,2023,39(11):2635-2642
                   cirrhosis[J]. Liver Transpl,2007,13(8):1174-1180  GUO B C,LI Y H,CHEN R,et al. Value of MELD 3.0,
             [12]KARNAM R S,CHEN S,XU W,et al. Sex disparity in liver                         (下转第1185页)
   97   98   99   100   101   102   103   104   105   106   107